25.61
0.01 (0.04%)
| Penutupan Terdahulu | 25.60 |
| Buka | 25.58 |
| Jumlah Dagangan | 410,478 |
| Purata Dagangan (3B) | 527,937 |
| Modal Pasaran | 1,007,700,352 |
| Harga / Pendapatan (P/E TTM) | 197.00 |
| Harga / Pendapatan (P/E Ke hadapan) | 8.83 |
| Harga / Jualan (P/S) | 1.54 |
| Harga / Buku (P/B) | 1.56 |
| Julat 52 Minggu |
| Margin Keuntungan | -14.76% |
| Margin Operasi (TTM) | 4.63% |
| EPS Cair (TTM) | -2.24 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 1.10% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -46.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 79.70% |
| Nisbah Semasa (MRQ) | 2.41 |
| Aliran Tunai Operasi (OCF TTM) | 175.75 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 144.75 M |
| Pulangan Atas Aset (ROA TTM) | 3.56% |
| Pulangan Atas Ekuiti (ROE TTM) | -12.27% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Menaik |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Bercampur | |
| Stok | Pacira BioSciences, Inc. | Bercampur | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -4.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 4.0 |
| Purata | 0.67 |
|
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 1.79% |
| % Dimiliki oleh Institusi | 110.89% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |